New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
08:39 EDTABMDAbiomed strength should be used as a selling opportunity, says Northland
Northland Securities recommends using any strength today as a selling opportunity and said the FDA close-out letter has nothing to do with the Department of Justice/Hippa investigation on off-label marketing. Shares are Underperform rated with a $9 price target.
News For ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
07:07 EDTABMDAbiomed sees Q4 revenue $90M, consensus $85.11M
Subscribe for More Information
07:07 EDTABMDAbiomed raises FY16 revenue outlook to $326M from $305M-$315M
Subscribe for More Information
07:06 EDTABMDAbiomed reports Q3 EPS 23c, consensus 15c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use